Evidence map›Paper›PMID 36000124›Full record

ArticleCureus2022

Rituximab-Induced Interstitial Lung Disease: A Stitch in Time Saved Nine.

Sai Tej, Asha Undrajavarapu, Kirti Kadian, Alkesh Khurana, Abhishek Goyal

Abstract readCase Reports
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sai TejPulmonary and Critical Care Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Asha UndrajavarapuPulmonary and Critical Care Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Kirti KadianPulmonary and Critical Care Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Alkesh KhuranaPulmonary and Critical Care Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.
Abhishek GoyalPulmonary and Critical Care Medicine, All India Institute of Medical Sciences, Bhopal, Bhopal, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 59-year-old male was initially diagnosed with pemphigus Vulgaris and received rituximab after a suboptimal clinical response with low-dose steroids and cyclophosphamide. Shortly after the third dose, he had acute interstitial pneumonia which was attributed to rituximab as there were no signs of any infective etiology after a detailed workup. He was put on mechanical ventilation but the dramatic response to pulse steroids helped the patient in early extubation and a favorable outcome.

Indexed as

ct scanildpemphigusrituximabsteroids

Identifiers

PMID36000124
PMCPMC9391763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.